Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer

Lukas Käsmann, Stefan Janssen, Steven E. Schild, Dirk Rades*

*Corresponding author for this work


Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all patients. To contribute to better personalization of the radiochemotherapy programs, this study compared two radiotherapy doses and 10 characteristics for survival. Patients and Methods: In 71 patients receiving radiochemotherapy for small-cell lung cancer, the radiation dose given as equivalent dose in 2 Gy fractions (EQD2: <56 vs. ?56 Gy) plus 10 characteristics, namely gender, age, Karnofsky performance score, T-category, Ncategory, tumor stage, pack years, smoking during radiotherapy, respiratory insufficiency and hemoglobin prior to radiotherapy, were evaluated for survival. Results: On multivariate analysis, EQD2 ?56 Gy (p=0.003), female gender (p=0.029), Karnofsky performance score >70 (p<0.001), very limited disease (p=0.043) and pre-radiotherapy hemoglobin ?12 g/dl (p=0.044) were significantly associated with better survival. Conclusion: This study identified several independent predictors of survival after radiochemotherapy of small-cell lung cancer. A radiation dose of ?56 Gy resulted in better survival than lower doses.

Original languageEnglish
JournalAnticancer Research
Issue number3
Pages (from-to)1089-1092
Number of pages4
Publication statusPublished - 03.2016


Dive into the research topics of 'Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer'. Together they form a unique fingerprint.

Cite this